Archer Daniels Midland (ADM)
NYSEConsumer StaplesFarm ProductsSnapshot 2026-07-08
$80.28+2.65%
Close 2026-07-08 · 1-day change
Reading ADM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ADM free→NYSEConsumer StaplesFarm ProductsSnapshot 2026-07-08
Reading ADM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ADM free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder in the Consumer Staples sector. The current thesis state is intact, supported by robust earnings quality and strong recent financial performance, despite facing sector headwinds.
The market appears to have priced in a justified valuation, with ADM trading at a premium compared to peers. The expectations gap is minimal, indicating that investors are not anticipating significant changes in performance.
Fundamentals are likely to remain stable, as management has shown a commitment to achieving adjusted EPS targets, although progress has been limited. The near-term risk of missing earnings is low, but the industry has a history of volatility.
The long-term thesis hinges on the performance of sector bellwethers like BG, TSN, and CALM. Positive earnings and guidance from these companies could support ADM, while negative trends could pose risks.
Overall, ADM's position is stable, but it faces challenges from the broader sector dynamics. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The recent guidance raise and upgraded earnings outlook support expectations for earnings growth, enhancing the overall thesis for ADM. There are no significant threats noted that could weaken this positive view.
as of 2026-07-08
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: This earnings report will show ADM's financial health and how it operates.
Confirms one read:The earnings report shows better financial results than the last quarter.
Confirms the other:The earnings report shows a drop in key financial results.
Why it matters: The Nutrition segment's performance is key for ADM's growth. Clear outlook can help investors.
Confirms one read:ADM shares a good update on the Nutrition segment's performance and outlook.
Confirms the other:ADM pulls back guidance or gives a negative outlook for the Nutrition segment.
Why it matters: Meeting the adjusted EPS target shows better financial results. It also shows good management.
Confirms:Adjusted EPS for 2026 reaches the higher end of the target range of $4.15-$4.70.
Disproves:Adjusted EPS for 2026 falls below the lower end of the target range of $4.15.
Why it matters: Managing capital spending is important for ADM's growth plan. Changes may show new focus.
Confirms one read:ADM says it will spend more than $1.3 to $1.5 billion.
Confirms the other:ADM lowers capital spending guidance to below $1.3 billion.
Why it matters: The SEC investigation's result could affect ADM's reputation and finances. This is key for gaining investor trust.
Confirms:The SEC investigation ends with no actions or penalties against ADM.
Disproves:The SEC will add penalties or actions against ADM after the investigation.
Why it matters: The CFO's investigation result may change how ADM handles its money.
Confirms one read:The Board says the investigation is over and no more actions are needed.
Confirms the other:The investigation finds serious problems that lead to more actions against ADM.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.